about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesAldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsBone microenvironment signals in osteosarcoma development.Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.
P50
Q26745742-29867548-BAB3-4F74-BCC5-401BE0275587Q27342050-569BB045-BBAA-4E68-AA9A-6AB5F0DEAB79Q28597747-AEF49A89-A85B-4701-B420-847A269E92F6Q33649056-FF0FC9CB-037D-41AE-9E8D-7C50454646CAQ38454980-B086924D-33FA-48C1-BCF9-A6A6F45C930CQ39032517-574244F2-EF3E-4EB9-9459-5BCCF152FE0AQ47391013-E3243585-4E92-420E-B10D-86FB24CD1089
P50
description
investigador
@es
researcher
@en
name
Lucia Martinez-Cruzado
@en
type
label
Lucia Martinez-Cruzado
@en
prefLabel
Lucia Martinez-Cruzado
@en
P31
P496
0000-0002-7170-932X